ReviewJSES international2025
Influence of preoperative diagnosis on outcomes after reverse total shoulder arthroplasty: a systematic review.
Review in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reverse total shoulder arthroplasty (rTSA) is currently used to treat a variety of preoperative diagnoses. Patient outcomes after rTSA may be affected by the indication in which it is used to treat. Methods: A literature search of the PubMed and MEDLINE databases was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. Studies were included if they reported patient-reported outcome measures (PROMs) following rTSA for the following preoperative indications: glenohumeral osteoarthritis, acute proximal humerus fracture (PHF), chronic PHF sequelae, inflammatory arthritis, revision arthroplasty, humeral head avascular necrosis, massive rotator cuff tear without arthritis, and rotator cuff tear arthropathy. The most used PROMs among the studies were the American Shoulder and Elbow Surgeons shoulder score and the Single Assessment Numeric Evaluation or the Subjective Shoulder Value. Forward elevation and external rotation were also evaluated. Results: There were 30 studies from the literature review that met inclusion criteria with a total of 3,463 patients. The average age of included patients ranged from 60 to 84 years. All studies reported improved American Shoulder and Elbow Surgeons and Single Assessment Numeric Evaluation or Subjective Shoulder Value scores as well as improved range of motion following rTSA. Patients who underwent rTSA for acute or chronic PHF or failed primary arthroplasty reported lower PROMs when compared to patients undergoing rTSA for other conditions of the glenohumeral joint. Conclusion: Understanding the influence of preoperative diagnosis on rTSA outcomes can assist clinicians with preoperative risk stratification as well as managing patient expectations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.